文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

达比加群通过非凝血酶依赖机制预防脂多糖介导的斑马鱼凋亡

Dabigatran Prevents Lipopolysaccharide-Mediated Apoptosis in Zebrafish Through a Thrombin-Independent Mechanism.
PubMed 文献 · Shock · 2026-01-28
一句话结论在斑马鱼内毒素血症模型中,达比加群经非抗凝机制减少炎症因子、一氧化氮和凋亡,完全防止脂多糖致死。

研究利用脂多糖诱导的斑马鱼内毒素血症模型,对脂多糖处理幼虫进行转录组研究并行计算机分析,同时用超过1500种美国食品药品监督管理局批准化合物进行体内筛选,发现多种减少炎症和防止脂多糖毒性的小分子。重点研究通过体内和计算机分析共同鉴定的直接凝血酶抑制剂达比加群,发现其共给药显著降低炎症细胞因子表达并完全保护斑马鱼免于脂多糖内毒素致死。该保护在凝血酶原突变鱼中仍存在,证明不依赖达比加群的抗凝功能;达比加群还显著减少一氧化氮产生和凋亡。作者认为这些发现及其他鉴定的小分子值得在包括脓毒症在内的炎症性疾病中进一步探索。

要点

  • 在脂多糖处理的斑马鱼幼虫中,达比加群共给药显著降低炎症细胞因子表达。
  • 达比加群共给药完全保护斑马鱼免于脂多糖内毒素致死。
  • 保护作用在凝血酶原突变鱼中仍出现,证明不依赖达比加群的抗凝功能。
  • 与单用脂多糖相比,达比加群显著减少一氧化氮产生和凋亡。
  • 作者认为达比加群及其他鉴定的小分子值得在包括脓毒症在内的炎症性疾病中进一步探索。

适用人群与场景

  • 脂多糖诱导内毒素血症的斑马鱼幼虫模型;凝血酶原突变斑马鱼用于验证机制。

研究设计与关键结果

  • 研究类型为动物实验(斑马鱼内毒素血症模型),对脂多糖处理幼虫进行转录组研究和计算机分析,并用超过1500种美国食品药品监督管理局批准化合物进行体内筛选。
  • 达比加群通过体内和计算机分析共同鉴定,共给药显著降低炎症细胞因子表达并完全保护斑马鱼免于脂多糖内毒素致死。
  • 保护作用在凝血酶原突变鱼中出现,证明不依赖达比加群的抗凝功能。
  • 与单用脂多糖相比,达比加群给药显著减少一氧化氮产生和凋亡。

证据类型、等级与局限

  • 证据类型:动物实验(斑马鱼模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文结论为达比加群通过非凝血酶依赖机制减少一氧化氮产生和凋亡,作者认为达比加群及其他鉴定的小分子值得在包括脓毒症在内的炎症性疾病中进一步探索;原文未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Endotoxemia is a feature of sepsis pathogenesis and has also been found to mediate the pathophysiology of multiple inflammatory conditions. In this work, we use a lipopolysaccharide (LPS) induced endotoxemia model in zebrafish to identify novel mediators of LPS toxicity. We performed transcriptomic studies on LPS-treated larvae, followed by in silico analysis, which revealed associations between the signatures of LPS-treated embryos and those of drugs involving diverse pathways. In parallel, we performed an in vivo screen using >1,500 Food and Drug Administration-approved compounds and identified multiple novel small molecules that reduced inflammation and prevented LPS toxicity. We focused on the direct thrombin inhibitor dabigatran, which was identified through both the in vivo and in silico analyses. We found that dabigatran coadministration significantly reduced the expression of inflammatory cytokines and completely protected zebrafish from endotoxemic death due to LPS. Surprisingly, we found that this protection occurs in prothrombin mutant fish, proving that protection from endotoxemia occurs independently of the anticoagulant function of dabigatran. We additionally found that dabigatran administration significantly decreased nitric oxide production and apoptosis compared with LPS treatment alone, suggesting possible mechanisms by which protection from endotoxemia is achieved. In summary, we identify several novel small molecules that prevent LPS-induced endotoxemia and show that one such small molecule, dabigatran, exerts a thrombin-independent effect on nitric oxide production and apoptosis. This and the other identified small molecules warrant further exploration in inflammatory conditions including sepsis. This manuscript discusses an off-label use of dabigatran.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Fleischmann AIT, Woodhams WH, Mouayed R, et al. Dabigatran Prevents Lipopolysaccharide-Mediated Apoptosis in Zebrafish Through a Thrombin-Independent Mechanism. Shock. 2026. PMID: 41593847. doi:10.1097/SHK.0000000000002798

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。